Home › Bronchiolitis Obliterans Syndrome › Pennsylvania › Pittsburgh
Bronchiolitis Obliterans Syndrome clinical trials in Pittsburgh, PA
5 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
RecruitingPhase 2
- Childrens Hospital of Pittsburgh, Pittsburgh
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
RecruitingPhase 3
- Upmc Hillman Cancer Center, Pittsburgh
Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
RecruitingHealthy volunteers welcome
- University of Pittsburgh, Pittsburgh
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
RecruitingPhase 2
- University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- UPMC Hillman Cancer Center, Pittsburgh
Bronchiolitis Obliterans Syndrome trials in other cities
- Boston, MA13 studies
- Seattle, WA11 studies
- Atlanta, GA10 studies
- New York City, NY9 studies
- Houston, TX8 studies
- Los Angeles, CA7 studies
- Miami, FL7 studies
- Baldwin Park, CA6 studies
- Durham, NC6 studies
- Tampa, FL6 studies
- Philadelphia, PA6 studies
- Washington, DC6 studies
Other studies in Pittsburgh
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)41 studies
- Breast Cancer39 studies
- Colorectal Cancer32 studies
- Metastatic Cancer31 studies
- Melanoma31 studies
- Ovarian Cancer30 studies
- Endometrial Cancer23 studies
- Prostate Cancer23 studies
- Lung Cancer23 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.